<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Timing of hypertonic saline inhalation for cystic fibrosis - Elkins, M - 2020 | Cochrane Library</title> <meta content="Timing of hypertonic saline inhalation for cystic fibrosis - Elkins, M - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008816.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Timing of hypertonic saline inhalation for cystic fibrosis - Elkins, M - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008816.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008816.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Timing of hypertonic saline inhalation for cystic fibrosis" name="citation_title"/> <meta content="Mark Elkins" name="citation_author"/> <meta content="University of Sydney" name="citation_author_institution"/> <meta content="mark.elkins@sydney.edu.au" name="citation_author_email"/> <meta content="Ruth Dentice" name="citation_author"/> <meta content="Royal Prince Alfred Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD008816.pub4" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/02/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008816.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008816.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008816.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Mucociliary Clearance; Administration, Inhalation; Cystic Fibrosis [*drug therapy]; Drug Administration Schedule; Saline Solution, Hypertonic [administration &amp; dosage, *therapeutic use]; Sputum [metabolism]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008816.pub4&amp;doi=10.1002/14651858.CD008816.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xsb6SJyC";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008816\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008816\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fr","zh_HANS","fa","ko","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008816.pub4",title:"Timing of hypertonic saline inhalation for cystic fibrosis",firstPublishedDate:"Feb 28, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008816.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008816.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008816.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008816.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008816.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008816.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008816.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008816.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008816.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008816.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2499 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008816.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0121"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-sec-0116"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/appendices#CD008816-sec-0126"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/table_n/CD008816StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/table_n/CD008816StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Timing of hypertonic saline inhalation for cystic fibrosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information#CD008816-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Mark Elkins</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information#CD008816-cr-0003">Ruth Dentice</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information/en#CD008816-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 February 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008816.pub4">https://doi.org/10.1002/14651858.CD008816.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008816-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008816-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008816-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008816-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008816-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008816-abs-0010">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008816-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008816-abs-0001" lang="en"> <section id="CD008816-sec-0001"> <h3 class="title" id="CD008816-sec-0001">Background</h3> <p>Inhalation of hypertonic saline improves sputum rheology, accelerates mucociliary clearance and improves clinical outcomes of people with cystic fibrosis. This is an update of a previously published Cochrane Review. </p> </section> <section id="CD008816-sec-0002"> <h3 class="title" id="CD008816-sec-0002">Objectives</h3> <p>To determine whether the timing of hypertonic saline inhalation (in relation to airway clearance techniques or in relation to time of day) has an impact on its clinical efficacy in people with cystic fibrosis. </p> </section> <section id="CD008816-sec-0003"> <h3 class="title" id="CD008816-sec-0003">Search methods</h3> <p>We identified relevant randomised and quasi‐randomised controlled trials from the Cochrane Cystic Fibrosis Trials Register, the Physiotherapy Evidence Database (PEDro), and international cystic fibrosis conference proceedings. </p> <p>Date of the last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Cystic Fibrosis Trials Register: 28 February 2019. </p> </section> <section id="CD008816-sec-0004"> <h3 class="title" id="CD008816-sec-0004">Selection criteria</h3> <p>Any trial of hypertonic saline in people with cystic fibrosis where timing of inhalation was the randomised element in the study protocol with either: inhalation up to six hours before airway clearance techniques compared to inhalation during airway clearance techniques compared to inhalation up to six hours after airway clearance techniques; or morning compared to evening inhalation with any definition provided by the author. </p> </section> <section id="CD008816-sec-0005"> <h3 class="title" id="CD008816-sec-0005">Data collection and analysis</h3> <p>Both authors independently assessed the trials identified by the search for potential inclusion in the review. The certainty of the evidence was assessed using GRADE. </p> </section> <section id="CD008816-sec-0006"> <h3 class="title" id="CD008816-sec-0006">Main results</h3> <p>The searches identified 104 trial reports which represented 51 trials, of which three cross‐over trials (providing data on 77 participants) met our inclusion criteria. We present three comparisons: inhalation before versus during airway clearance techniques; inhalation before versus after airway clearance techniques; and inhalation during versus after airway clearance techniques. One trial (50 participants), given its three‐arm design, was eligible for all three comparisons. No trials compared morning versus evening inhalation of hypertonic saline. </p> <p>The evidence from the three trials was judged to be of low quality downgraded for limitations (high risk of bias due to blinding) and indirectness (all participants are adults, and therefore not applicable to children). Intervention periods ranged from one treatment to three treatments in one day. There were no clinically important differences between the timing regimens of inhaling hypertonic saline before, during or after airway clearance techniques in the mean amount of improvement in lung function or symptom scores (77 participants), with the between‐group comparisons being non‐significant (low‐certainty evidence). While there may be little or no difference in the rating of satisfaction when hypertonic saline was inhaled before versus during the airway clearance techniques (64 participants) (with the 95% confidence interval including the possibility of both a higher and lower rating of satisfaction), satisfaction may be lower on a 100‐mm scale when inhaled after the airway clearance techniques compared to before: mean difference (MD) 20.38 mm (95% confidence interval (CI) 12.10 to 28.66) and when compared to during the techniques, MD 14.80 mm (95% CI 5.70 to 23.90). Perceived effectiveness showed similar results: little or no difference for inhalation before versus during airway clearance techniques (64 participants); may be lower when inhaled after the airway clearance techniques compared to before, MD 10.62 (95% CI 2.54 to 18.70); and also when compared to during the techniques, MD 15.60 (95% CI 7.55 to 23.65). There were no quality of life or adverse events reported in any of the trials. </p> </section> <section id="CD008816-sec-0007"> <h3 class="title" id="CD008816-sec-0007">Authors' conclusions</h3> <p>Timing of hypertonic saline inhalation makes little or no difference to lung function (low‐certainty evidence). However, inhaling hypertonic saline before or during airway clearance techniques may maximise perceived efficacy and satisfaction. The long‐term efficacy of hypertonic saline has only been established for twice‐daily inhalations; however, if only one dose per day is tolerated, the time of day at which it is inhaled could be based on convenience or tolerability until evidence comparing these regimens is available. </p> <p>The identified trials were all of very short intervention periods, so longer‐term research could be conducted to establish the effects arising from regular use, which would incorporate the influence of changes in adherence with long‐term use, as well as generating data on any adverse effects that occur with long‐term use. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008816-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008816-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008816-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008816-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008816-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD008816-abs-0011">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008816-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008816-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008816-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008816-abs-0003" lang="en"> <h3>The timing of inhalation of hypertonic saline in people with cystic fibrosis</h3> <p><b>Review question</b> </p> <p>We reviewed the evidence about whether the timing (in relation to airway clearance techniques or in relation to time of day) of hypertonic saline (a strong, sterile, salt water solution) through a nebuliser improves the physical properties of sputum, stimulates cough, improves clinical outcomes (such as lung function), and improves the perceived effect of airway clearance techniques in cystic fibrosis. This is an update of a previously published Cochrane Review. </p> <p><b>Background</b> </p> <p>Regular inhalation of hypertonic saline improves the clinical outcomes of people with cystic fibrosis. It is not certain whether it is better to inhale hypertonic saline before, during or after clearing the airways with physical techniques, nor whether it is better to inhale it in the morning or in the evening. We looked for trials that compared these different timing regimens. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 28 February 2019.</p> <p><b>Study characteristics</b> </p> <p>The review included three studies with 77 people with cystic fibrosis aged between 18 and 64 years of age<i>.</i> The studies looked at the impact of the timing of hypertonic saline inhalation in relation to airway clearance techniques. The studies reported immediate outcomes after inhalation of hypertonic saline before, during or after physical airway clearance techniques. All studies were short, involving only one to three treatments of each timing regimen. </p> <p><b>Key results</b> </p> <p>While outcomes such as lung function did not show any difference between the regimens, people with cystic fibrosis perceived that inhaling hypertonic saline before or during airway clearance techniques may be more effective and satisfying than inhaling hypertonic saline after airway clearance. No studies comparing morning and evening inhalation were found. The long‐term efficacy of hypertonic saline has only been established for twice‐daily inhalations; however, if only one dose per day is tolerated, the time of day at which it is inhaled could be based on convenience or tolerability until further evidence is available. </p> <p><b>Quality of the evidence</b> </p> <p>Overall, the quality of the evidence was low. The only issues perhaps affecting the quality related to the fact that it was not possible for participants to be blinded to the treatment they received. However, because the studies were short‐term and most of the significant results were based on perceived efficacy, timing of administration of hypertonic saline needs further study. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008816-sec-0121" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008816-sec-0121"></div> <h3 class="title" id="CD008816-sec-0122">Implications for practice</h3> <section id="CD008816-sec-0122"> <p>The included trials identified that the timing of hypertonic saline in relation to physical airway clearance techniques did not have a substantial effect on the change in lung function, lung clearance index, functional residual capacity, sputum wet weight, dyspnoea or cough after a single treatment session. However, participants may be more satisfied with the entire treatment session when hypertonic saline was inhaled before or during the physical airway clearance techniques – presumably because these timing regimens were perceived as more effective than inhaling hypertonic saline after the techniques. This may have important implications for long‐term adherence, which is known to be low for both hypertonic saline and physical airway clearance techniques (<a href="./references#CD008816-bbs2-0050" title="AbbottJ , DoddME , WebbAK . Adherence with the use of clearance techniques. In: RubinBK , van derSchansCP editor(s). Therapy for Mucus‐Clearance Disorders. New York: Marcel Dekker, 2004:105‐128. ">Abbott 2004</a>; <a href="./references#CD008816-bbs2-0062" title="ElkinsMR , ByePT . Inhaled hypertonic saline as a therapy for cystic fibrosis. Current Opinion in Pulmonary Medicine2006;12(6):445‐52. ">Elkins 2006b</a>). </p> <p>Perceived efficacy and satisfaction were lower when hypertonic saline was inhaled after physical airway clearance techniques than with the other timing regimens. Inhalation of hypertonic saline after the physical techniques may fail to capitalise on effects of hypertonic saline on mucus clearance if techniques to promote expectoration are not undertaken until four to six hours later. </p> <p>On the basis of these results, we suggest that adults with cystic fibrosis who use hypertonic saline and physical airway clearance techniques to inhale the saline before or during the physical techniques. The hypertonic saline should also be inhaled after a bronchodilator as was the protocol in the three included trials, because it has previously been established that this is necessary to prevent bronchoconstriction (<a href="./references#CD008816-bbs2-0056" title="ByePTP , ElkinsMR . Other mucoactive agents for cystic fibrosis. Paediatric Respiratory Reviews2007;8:30‐9. ">Bye 2007</a>). </p> <p>This review did not identify any evidence comparing the timing of hypertonic saline inhalation in relation to time of day. Until such evidence becomes available, clinicians could advise patients to inhale hypertonic saline twice daily; but if only one dose per day is tolerated, the time of day at which it is inhaled could be based on convenience or tolerability. </p> </section> <h3 class="title" id="CD008816-sec-0123">Implications for research</h3> <section id="CD008816-sec-0123"> <p>Any effect of the timing regimens on forced expiratory volume at one second (FEV<sub>1</sub>) was minor. The mean differences and their 95% confidence intervals (CIs) were all well below 150 mL (the a priori smallest worthwhile effect in the Dentice trial), and equated to approximately 1% of the predicted normal value (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). Therefore, although the mean results favoured inhalation of hypertonic saline before physical airway clearance techniques, any effects of the timing regimens on FEV<sub>1</sub> are probably too small to be clinically important. However, unlike the narrow confidence intervals seen in the FEV<sub>1</sub> data, some of the between‐group comparisons for forced vital capacity (FVC) had much wider 95% CIs, suggesting that further research could modify the estimate. For example, inhaling hypertonic saline before physical airway clearance techniques might increase the improvement in FVC by as much as 180 mL more than inhaling it during or after the techniques. Therefore, further data could be obtained to make the estimate of the effect on FVC more precise and then to determine whether one timing regimen has a clinically important benefit over another.  </p> <p>In addition, the trials were all of very short intervention periods, so longer‐term research could be conducted to establish the effects arising from regular use, which would incorporate the influence of changes in adherence with long‐term use, as well as generating data on any adverse effects that occur with long‐term use. </p> <p>Devices that combine nebulisation with (oscillating) PEP have the potential to improve adherence to therapy because they may substantially reduce the overall treatment duration (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). However, a benchtop study has demonstrated that the delivered dose decreases by 84% when delivered via the Acapella Duet (<a href="./references#CD008816-bbs2-0053" title="BerlinskiA . In vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respiratory Care2014;59(2):216‐22. ">Berlinski 2014</a>), presumably due to obstruction of the aerosol pathway. Several studies suggest that when the dose of salt received is reduced, there is a reduction in hypertonic saline's effect on sputum rheology (<a href="./references#CD008816-bbs2-0068" title="KingM , DasguptaB , TomkiewiczRP , BrownNE . Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. American Journal of Respiratory and Critical Care Medicine1997;156(1):173‐7. ">King 1997</a>; <a href="./references#CD008816-bbs2-0078" title="WillsPJ , HallRL , ChanW , ColePJ . Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus‐depleted bovine trachea. Journal of Clinical Investigation1997;99(1):9‐13. ">Wills 1997</a>), mucociliary clearance (<a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>), and perhaps some clinical outcomes (<a href="./references#CD008816-bbs2-0062" title="ElkinsMR , ByePT . Inhaled hypertonic saline as a therapy for cystic fibrosis. Current Opinion in Pulmonary Medicine2006;12(6):445‐52. ">Elkins 2006b</a>). These issues warrant further investigation so that an informed recommendation can be made regarding nebulisers that incorporate PEP or oscillating PEP mechanisms that obstruct the aerosol pathway. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008816-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008816-sec-0015"></div> <div class="table" id="CD008816-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhalation before compared with during airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation before compared with during airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation before airway clearance techniques </p> <p><b>Comparison</b>: inhalation during airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation during airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation before airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to ˜2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.56% higher</b> (0.48% lower to 1.60% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>2.09% higher</b> (0.08% higher to 4.11% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All of the symptom scores suggest no statistically significant difference between the groups. </p> <p>This outcome includes a range of symptom scores from many different studies but number of participants contributing to each symptom score varies. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance: sputum wet weight immediately (g)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean wet weight of sputum during the application of the intervention was <b>0.26 g lower</b> (4.79 g lower to 4.27 g higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean wet weight of sputum for the 24 hours following treatment suggests no statistically significant difference between the groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> <p><b>Follow‐up: 90 minutes later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean LCI was <b>0.02 lower</b> (0.63 lower to 0.59 higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean LCI immediately after treatment suggests no statistically significant difference between the groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008816-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhalation before compared with after airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation before compared with after airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation before airway clearance techniques </p> <p><b>Comparison</b>: inhalation after airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation after airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation before airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.75% higher</b> (0.45% lower to 1.95% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>1.66% higher</b> (1.42% lower to 4.74% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FVC (L) showed no statistically significant difference between groups.</p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three symptom scores have been presented:</p> <p>Perceived efficacy shows a statistically significant difference in favour of inhalation before airway clearance techniques (MD 10.62; 95% CI 2.54 to 18.70) </p> <p>Tolerability showed no statistically significant difference between groups.</p> <p>Satisfaction shows a statistically significant difference in favour of inhalation before airway clearance techniques, MD 20.38 (95% CI 12.10 to 28.66) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008816-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhalation during compared with after airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation during compared with after airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation during airway clearance techniques </p> <p><b>Comparison</b>: Inhalation after airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation after airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation during airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.03% lower</b> (1.19% lower to 1.12% higher) in the inhalation during airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>0.44% lower</b> (3.34% lower to 2.46% higher) in the inhalation during airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FVC (L) also showed no statistically significant difference between groups.</p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three symptom scores have been presented:</p> <p>Perceived efficacy shows a statistically significant difference in favour of inhalation during airway clearance techniques, MD 15.60 (95% CI 7.55 to 23.65) </p> <p>Tolerability showed no statistically significant difference between groups.</p> <p>Satisfaction shows a statistically significant difference in favour of inhalation during airway clearance techniques, MD 14.80 (95% CI 5.70 to 23.90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : Mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008816-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008816-sec-0016"></div> <section id="CD008816-sec-0017"> <h3 class="title" id="CD008816-sec-0017">Description of the condition</h3> <p>Cystic fibrosis (CF) is the most common life‐limiting autosomal recessive disorder amongst Caucasians (<a href="./references#CD008816-bbs2-0057" title="CuttingGR . Cystic fibrosis. In: RimonDL , ConnorJM , PyeritzRE , KorfBR editor(s). Principles and Practice of Medical Genetics. 4th Edition. London: Harcourt, 2002:1561‐606. ">Cutting 2002</a>). Mucociliary clearance is impaired in CF (<a href="./references#CD008816-bbs2-0039" title="RobinsonM , RegnisJA , BaileyDL , KingM , BautovichGJ , ByePT . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;153(5):1503‐9. ">Robinson 1996</a>; <a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>). Cystic fibrosis‐related pulmonary disease is the major cause of morbidity and mortality (<a href="./references#CD008816-bbs2-0055" title="BuzzettiR , SalvatoreD , BaldoE , FornerisMP , LucidiV , ManunzaD , et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. Journal of Cystic Fibrosis2009;8(4):229‐37. ">Buzzetti 2009</a>). </p> </section> <section id="CD008816-sec-0018"> <h3 class="title" id="CD008816-sec-0018">Description of the intervention</h3> <p>Hypertonic saline is a sterile salt‐water solution delivered as a nebulised therapy, usually at a concentration of between 3% and 10% (composition by mass). Traditionally, volumes of 3 mL to 10 mL are nebulised (<a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0077" title="WarkPAB , McDonaldVM . Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews2018, Issue 9. [DOI: 10.1002/14651858.CD001506.pub4] ">Wark 2018</a>). Long‐term use is recommended (<a href="./references#CD008816-bbs2-0054" title="ButtonBM , WilsonC , DenticeR , CoxNS , MiddletonA , TannenbaumE , et al. Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline. Respirology2016;21:656‐67. ">Button 2016</a>). </p> <p>Each dose of hypertonic saline is usually nebulised immediately prior to airway clearance, but other timing regimens are sometimes used in clinical practice. The clinical effect of hypertonic saline could be affected by the timing of its delivery in relation to physical airway clearance techniques (before, during or after) or in relation to time of day (morning or evening). </p> </section> <section id="CD008816-sec-0019"> <h3 class="title" id="CD008816-sec-0019">How the intervention might work</h3> <p>Hypertonic saline has been shown to accelerate mucociliary clearance in the CF airway (<a href="./references#CD008816-bbs2-0039" title="RobinsonM , RegnisJA , BaileyDL , KingM , BautovichGJ , ByePT . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;153(5):1503‐9. ">Robinson 1996</a>; <a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>). Three mechanisms are believed to contribute to this improvement in mucociliary clearance. The first is restoration of the depleted airway surface liquid volume, which peaks almost immediately after a dose, but which may be sustained for several hours (<a href="./references#CD008816-bbs2-0019" title="DonaldsonSH , BennettW , ZemanK , KnowlesMR , BoucherRC . Efficacy of amiloride and hypertonic saline in cystic fibrosis. Pediatric Pulmonology2003;Suppl 25:251. [CFGD Register: BD110a] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine2006;354(3):241‐50. [CFGD Register: BD110b] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Online Supplement to 'Mucus clearance and lung function in cystic fibrosis with hypertonic saline' [online supplement]. New England Journal of Medicine2006; Vol. 354, issue 3:241‐50. [CFGD Register: BD110c] ">Donaldson 2006</a>). The other mechanisms are improvement in the rheology of the mucus (<a href="./references#CD008816-bbs2-0068" title="KingM , DasguptaB , TomkiewiczRP , BrownNE . Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. American Journal of Respiratory and Critical Care Medicine1997;156(1):173‐7. ">King 1997</a>; <a href="./references#CD008816-bbs2-0078" title="WillsPJ , HallRL , ChanW , ColePJ . Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus‐depleted bovine trachea. Journal of Clinical Investigation1997;99(1):9‐13. ">Wills 1997</a>), and stimulation of cough (<a href="./references#CD008816-bbs2-0039" title="RobinsonM , RegnisJA , BaileyDL , KingM , BautovichGJ , ByePT . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;153(5):1503‐9. ">Robinson 1996</a>; <a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>). The overall effect on mucus clearance is presumably responsible for the significant clinical improvements including lung function, quality of life (QoL), and ease of expectoration with regular use of the therapy (<a href="./references#CD008816-bbs2-0062" title="ElkinsMR , ByePT . Inhaled hypertonic saline as a therapy for cystic fibrosis. Current Opinion in Pulmonary Medicine2006;12(6):445‐52. ">Elkins 2006b</a>; <a href="./references#CD008816-bbs2-0024" title="ButtonBM , RiedlerJ , ReadeT , EngP , RobertsonCF . Inhaled hypertonic saline as an adjunct to chest physiotherapy in cystic fibrosis: The three‐year clinical experience. Pediatric Pulmonology1996;22(Suppl 13):306. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Efficacy of short‐term ultrasonically nebulised hypertonic saline in patients with cystic fibrosis. European Respiratory Journal1995;8(Suppl 19):510s. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Short‐term administration of ultrasonically nebulised hypertonic saline improves pulmonary function in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1995;25:440. EngPA , MortonJ , DouglassJA , RiedlerJ , WilsonJ , RobertsonCF . Short‐term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatric Pulmonology1996;21(2):77‐83. [MEDLINE: 97036562] ">Eng 1996</a>). A Cochrane Review of nebulised hypertonic saline for CF concluded that improvements in forced expiratory volume at one second (FEV<sub>1</sub>) were demonstrated over two to four weeks of therapy and QoL and pulmonary exacerbation rates were improved compared to placebo interventions over 48 weeks of treatment (<a href="./references#CD008816-bbs2-0077" title="WarkPAB , McDonaldVM . Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews2018, Issue 9. [DOI: 10.1002/14651858.CD001506.pub4] ">Wark 2018</a>). </p> <p>In the controlled studies that established the efficacy of hypertonic saline (<a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0024" title="ButtonBM , RiedlerJ , ReadeT , EngP , RobertsonCF . Inhaled hypertonic saline as an adjunct to chest physiotherapy in cystic fibrosis: The three‐year clinical experience. Pediatric Pulmonology1996;22(Suppl 13):306. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Efficacy of short‐term ultrasonically nebulised hypertonic saline in patients with cystic fibrosis. European Respiratory Journal1995;8(Suppl 19):510s. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Short‐term administration of ultrasonically nebulised hypertonic saline improves pulmonary function in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1995;25:440. EngPA , MortonJ , DouglassJA , RiedlerJ , WilsonJ , RobertsonCF . Short‐term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatric Pulmonology1996;21(2):77‐83. [MEDLINE: 97036562] ">Eng 1996</a>; <a href="./references#CD008816-bbs2-0039" title="RobinsonM , RegnisJA , BaileyDL , KingM , BautovichGJ , ByePT . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;153(5):1503‐9. ">Robinson 1996</a>; <a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>), each dose was nebulised immediately before the administration of airway clearance techniques. However, other timing regimens may have advantages. Nebulisation of hypertonic saline <i>during</i> airway clearance techniques could save time. It also may capitalise on the immediate peak in the airway surface liquid volume. Nebulisation <i>after</i> airway clearance techniques may capitalise on the reduction in airway obstruction by mucus and therefore allow delivery of the hypertonic saline to a greater portion of the bronchial tree. </p> <p>In the clinical trials that established the efficacy of the regular use of hypertonic saline (<a href="./references#CD008816-bbs2-0019" title="DonaldsonSH , BennettW , ZemanK , KnowlesMR , BoucherRC . Efficacy of amiloride and hypertonic saline in cystic fibrosis. Pediatric Pulmonology2003;Suppl 25:251. [CFGD Register: BD110a] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine2006;354(3):241‐50. [CFGD Register: BD110b] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Online Supplement to 'Mucus clearance and lung function in cystic fibrosis with hypertonic saline' [online supplement]. New England Journal of Medicine2006; Vol. 354, issue 3:241‐50. [CFGD Register: BD110c] ">Donaldson 2006</a>; <a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0024" title="ButtonBM , RiedlerJ , ReadeT , EngP , RobertsonCF . Inhaled hypertonic saline as an adjunct to chest physiotherapy in cystic fibrosis: The three‐year clinical experience. Pediatric Pulmonology1996;22(Suppl 13):306. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Efficacy of short‐term ultrasonically nebulised hypertonic saline in patients with cystic fibrosis. European Respiratory Journal1995;8(Suppl 19):510s. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Short‐term administration of ultrasonically nebulised hypertonic saline improves pulmonary function in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1995;25:440. EngPA , MortonJ , DouglassJA , RiedlerJ , WilsonJ , RobertsonCF . Short‐term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatric Pulmonology1996;21(2):77‐83. [MEDLINE: 97036562] ">Eng 1996</a>), at least two doses per day were used. However, some individuals can tolerate (or for other reasons elect to use) only one dose per day. For these people, nebulising the dose at a particular time of the day may affect its efficacy. Given that spontaneous mucociliary clearance is faster during waking hours than sleep (<a href="./references#CD008816-bbs2-0052" title="BatemanJR , PaviaD , ClarkSW . The retention of lung secretions during the night in normal subjects. Clinical Science and Molecular Medicine. Supplement1978;55(6):523‐7. ">Bateman 1978</a>), morning inhalation of hypertonic saline may capitalise on faster daytime mucociliary clearance and on the mucus‐clearing effects of daytime activities such as exercise (<a href="./references#CD008816-bbs2-0079" title="WolffRK , DolovichMB , ObminskiG , NewhouseMT . Effects of exercise and eucapnic hyperventilation on bronchial clearance in man. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology1977;43(1):46‐50. ">Wolff 1977</a>). Some people with CF find evening inhalation more convenient or report that it improves ease of expectoration the following morning. Since mucociliary clearance and coughing are suppressed overnight, evening inhalation of hypertonic saline may increase its dwell time in the airways, possibly increasing its clinical efficacy. </p> </section> <section id="CD008816-sec-0020"> <h3 class="title" id="CD008816-sec-0020">Why it is important to do this review</h3> <p>Despite the theoretical rationales presented to justify the investigation of alternative timing regimens in the previous section, it is also possible that any timing regimen may have adverse effects on the efficacy, tolerability and convenience of the treatment and on the duration of the airway clearance session. For example, nebulisation of hypertonic saline during airway clearance techniques could increase the complexity of the overall session of airway clearance, perhaps requiring modified equipment. Nebulisation <i>after</i> airway clearance techniques presumably delivers the hypertonic saline more directly to the exposed airway epithelium, rather than an overlying mucus layer, which may reduce tolerability. Evening delivery may increase nocturnal coughing and sleep disturbance. Therefore, it is important to review well‐designed research that compares the regimens. </p> <p>There is a high treatment burden associated with CF for both people with the disease and for care providers. Hypertonic saline inhalation adds to the duration of the overall treatment regimen. Therefore, even if the various timing regimens have equal clinical efficacy, it is important that the review also investigates whether the interventions differ in their effects on the duration of the overall airway clearance session, in their convenience and in their side effects. </p> <p>This is an update of a previously published Cochrane Review (<a href="./references#CD008816-bbs2-0080" title="ElkinsM , DenticeR . Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD008816.pub2] ">Elkins 2012</a>; <a href="./references#CD008816-bbs2-0081" title="ElkinsM , DenticeR . Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD008816.pub2] ">Elkins 2016</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008816-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008816-sec-0021"></div> <p>To determine whether the timing of hypertonic saline inhalation, in relation to physical airway clearance techniques or time of day, has an impact on objective and subjective measures of clinical efficacy and tolerability in people with CF. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008816-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008816-sec-0022"></div> <section id="CD008816-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008816-sec-0024"> <h4 class="title">Types of studies</h4> <p>Randomised trials (published and unpublished). Both random allocation and quasi‐random allocation (e.g. where there is alternate allocation to groups) were included. Parallel and cross‐over trials were eligible. </p> </section> <section id="CD008816-sec-0025"> <h4 class="title">Types of participants</h4> <p>People of all ages and of both sexes with CF diagnosed by genetic testing or evidence on sweat chloride or nasal potential difference, including all degrees of disease severity. </p> </section> <section id="CD008816-sec-0026"> <h4 class="title">Types of interventions</h4> <p>Nebulised hypertonic saline, where timing of inhalation was the randomised element in the study protocol: </p> <p> <ol id="CD008816-list-0001"> <li> <p>hypertonic saline inhalation up to six hours before airway clearance techniques, compared to inhalation during airway clearance techniques; </p> </li> <li> <p>hypertonic saline inhalation up to six hours before airway clearance techniques, compared to up to six hours after airway clearance techniques; </p> </li> <li> <p>hypertonic saline inhalation during airway clearance techniques, compared to up to six hours after airway clearance techniques; </p> </li> <li> <p>morning compared to evening inhalation with any definition provided by the author. If not defined, we accepted midnight to midday as morning and midday to midnight as evening. </p> </li> </ol> </p> <p>Note: many individuals perform two treatments with physical airway clearance techniques each day. Even if these treatments are performed as far as possible from each other (i.e. 12 hours apart), any threshold greater than six hours would mean that the hypertonic saline labelled ‘before’ would actually be closer to ‘after’ the previous treatment with physical airway clearance techniques. Therefore, six hours is the broadest threshold possible to capture all potentially relevant trials. However, some of the mechanisms by which timing may affect the outcome are short‐lived. Therefore, a sensitivity analysis is performed that only considers trials where the hypertonic saline is within 30 min of the techniques (<i>see</i><a href="#CD008816-sec-0044">Sensitivity analysis</a>). </p> <p>The timing regimen could be a single treatment or could be maintained for any duration.</p> <p>Hypertonic saline treatment had to be a minimum of a single dose of at least 3% concentration. If studies mentioned co‐interventions (such as bronchodilators and other inhaled medications), these were permitted provided they were the same on all trial days and taken either before or after the period during which hypertonic saline and airway clearance techniques were used. </p> <p>Airway clearance techniques (ACT) had to be a minimum of 10 minutes in duration and include at least one of the following: </p> <p> <ol id="CD008816-list-0002"> <li> <p>postural drainage with percussion and vibration (PDPV). In other reviews this has been described as conventional chest physiotherapy (CCPT) (<a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0071" title="MainE , PrasadA , van derSchansCP . Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD002011.pub2] ">Main 2009</a>; <a href="./references#CD008816-bbs2-0076" title="van derSchansCP , PrasadA , MainE . Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD001401] ">van der Schans 2009</a>); </p> </li> <li> <p>active cycle of breathing techniques (ACBT).This comprises relaxation or breathing control, forced expiration technique (FET), thoracic expansion exercises and may include postural drainage or percussion (<a href="./references#CD008816-bbs2-0074" title="RobinsonKA , MckoyN , SaldanhaI , OdelolaOA . Active cycle of breathing technique for cystic fibrosis. Cochrane Database of Systematic Reviews2010, Issue 11. [DOI: 10.1002/14651858.CD007862.pub2] ">Robinson 2010</a>); </p> </li> <li> <p>autogenic drainage (AD). This breathing technique uses high expiratory flow rates at varying lung volumes to enhance mucus clearance while avoiding airway closure; </p> </li> <li> <p>positive expiratory pressure (PEP) (<a href="./references#CD008816-bbs2-0061" title="ElkinsM , JonesA , van derSchansCP . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003147.pub3] ">Elkins 2006a</a>); </p> </li> <li> <p>oral oscillatory devices that provide oscillating PEP (such as the Flutter, Cornet and Acapella) or intrapulmonary percussive ventilation, which provides continuous oscillation of the air pressure in the airways via the mouth (<a href="./references#CD008816-bbs2-0073" title="MorrisonL , AgnewJ . Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD006842.pub2] ">Morrison 2009</a>); </p> </li> <li> <p>thoracic oscillating devices applied via a vest to provide external chest wall oscillation (<a href="./references#CD008816-bbs2-0073" title="MorrisonL , AgnewJ . Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2009, Issue 1. [DOI: 10.1002/14651858.CD006842.pub2] ">Morrison 2009</a>); </p> </li> <li> <p>exercise prescribed for the purpose of airway clearance either independently or as an adjunct to other techniques. </p> </li> </ol> </p> </section> <section id="CD008816-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD008816-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008816-list-0003"> <li> <p>Lung function, i.e., change in lung function (measured in litres or % predicted). If change values are unavailable, final post‐treatment values will be used. Values in litres and in % predicted will be analysed separately. </p> <ol id="CD008816-list-0004"> <li> <p>forced expiratory volume at one second (FEV<sub>1</sub>) </p> </li> <li> <p>forced vital capacity (FVC)</p> </li> </ol> </li> <li> <p>Patient‐reported outcomes, using validated scales or subjective reporting measures</p> <ol id="CD008816-list-0005"> <li> <p>measures of QoL</p> </li> <li> <p>symptom scores (including cough, tolerability, subjective ease of clearance, or treatment satisfaction) </p> </li> </ol> </li> </ol> </p> </section> <section id="CD008816-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008816-list-0006"> <li> <p>Measures of sputum clearance, including measures of mucociliary clearance (assessed by radioactive tracer clearance) and objective measures of sputum volume </p> </li> <li> <p>Measures of exercise capacity (either maximal or submaximal where measured directly, or by a standard field test) </p> </li> <li> <p>Mortality (all cause or CF‐related, analysed separately)</p> </li> <li> <p>Other pulmonary parameters</p> <ol id="CD008816-list-0007"> <li> <p>forced expiratory flow between 25% and 75% of the vital capacity (FEF<sub>25‐75</sub>) </p> </li> <li> <p>maximal instantaneous forced flow when 25% of the FVC remains to be exhaled (MEF<sub>25</sub>) </p> </li> <li> <p>total lung capacity (TLC)</p> </li> <li> <p>residual volume (RV)</p> </li> <li> <p>functional residual capacity (FRC)</p> </li> <li> <p>lung clearance index (LCI)</p> </li> </ol> </li> <li> <p>Frequency of exacerbations of respiratory infection (where a clear definition is described demonstrating an increase in symptoms or a decline in pulmonary function) </p> <ol id="CD008816-list-0008"> <li> <p>admission rates to hospital (defined as either number of inpatient hospital admissions or days as a hospital inpatient) </p> </li> <li> <p>courses of IV antibiotics (whether received in hospital or in the home)</p> </li> <li> <p>outpatient treatments (presentations to hospital, unscheduled visits to the doctor)</p> </li> </ol> </li> <li> <p>Adherence to inhaled therapies, airway clearance techniques, and other therapies</p> </li> <li> <p>Adverse effects such as bronchospasm, cough and acute decline in pulmonary function</p> </li> </ol> </p> </section> </section> </section> <section id="CD008816-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <p>A comprehensive search strategy was formulated in an attempt to identify all relevant trials regardless of language or publication status (published, unpublished, in press, and in progress). </p> <section id="CD008816-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We identified relevant trials from the Cochrane Cystic Fibrosis and Genetic Disorders Group's Cystic Fibrosis Trials Register using the term 'hypertonic saline'. </p> <p>The Cystic Fibrosis Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of the Cochrane Library), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals ‐ <i>Pediatric Pulmonology</i> and the <i>Journal of Cystic Fibrosis</i>. Unpublished work was identified by searching the abstract books of relevant conferences, including the three major cystic fibrosis conferences: the International Cystic Fibrosis Conference, the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the Cochrane Cystic Fibrosis and Genetic Disorders Group's <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Cystic Fibrosis Trials Register: 28 February 2019. </p> <p>In addition, we searched the <a href="http://www.pedro.org.au/" target="_blank">Physiotherapy Evidence Database</a> (PEDro) (<a href="./references#CD008816-bbs2-0072" title="MIchaleffZA , CostaLOP , MoseleyAM , MaherCG , ElkinsMR , HerbertRD , et al. CENTRAL, PEDro, PubMed, and EMBASE are the most comprehensive databases indexing randomized controlled trials of physical therapy interventions. Physical Therapy2011;91(2):190‐7. ">Michaleff 2011</a>) and the <a href="http://apps.who.int/trialsearch/" target="_blank">WHO International Clinical Trials Registry Platform</a> for all years available (<a href="./appendices#CD008816-sec-0127">Appendix 1</a>; <a href="./appendices#CD008816-sec-0128">Appendix 2</a>). Date of last search: 21 February 2019. </p> </section> <section id="CD008816-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We hand‐searched the biennial Australia and New Zealand CF Conference Proceedings from 1995 to 2017. </p> <p>We contacted trial authors, experts and manufacturers of hypertonic saline to identify additional trials. </p> <p>We searched the reference lists of the included studies.</p> </section> </section> <section id="CD008816-sec-0033"> <h3 class="title" id="CD008816-sec-0033">Data collection and analysis</h3> <section id="CD008816-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Both authors (RD, ME) independently selected the trials to be included in the review. We performed initial screening by title and abstract, and reviewed the full text for studies remaining after the initial screening phase. We resolved disagreements by discussion. We excluded irrelevant records and have presented the details of these excluded trials and the reasons for exclusion in tabular form (<a href="./references#CD008816-sec-0139" title="">Characteristics of excluded studies</a>). </p> </section> <section id="CD008816-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Each author independently extracted data from the included studies using a standardised data extraction form. We resolved any disagreements by discussion. Where data were absent or difficult to interpret in the presented form, the authors contacted the trial investigators to gain the information required to evaluate risk of bias in the trial and to facilitate data analysis. Data extraction was also carried out at the editorial base for the Dentice trial given we (the Cochrane Review authors) are also two of the trial authors (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=95799186756631410581100324110614%26versionPK1=z1602251548287889754301749312605%26versionPK2=z1604181052193555586373418472833#STD-Dentice-2012" target="_blank">Dentice 2012</a>). </p> </section> <section id="CD008816-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We independently determined the risk of bias for each trial using published and unpublished data from the trial investigators, following the domain‐based evaluation as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions 5.1</i> (<a href="./references#CD008816-bbs2-0067" title="Higgins 2011: HigginsJPT , AltmanDG , SterneJAC , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.. ">Higgins 2011</a>). The risk of bias was also carried out at the editorial base for the Dentice trial given we (the Cochrane Review authors) are also two of the trial authors (<a href="https://archie.cochrane.org/sections/documents/viewDiff?documentPK=95799186756631410581100324110614%26versionPK1=z1602251548287889754301749312605%26versionPK2=z1604181052193555586373418472833#STD-Dentice-2012" target="_blank">Dentice 2012</a>). We assessed the following domains as either low risk, unclear risk, or high risk of bias: </p> <p> <ol id="CD008816-list-0009"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding (of participants, personnel and outcome assessors);</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting;</p> </li> <li> <p>other sources of bias.</p> </li> </ol> </p> <p>We resolved any disagreements by discussion. In addition, each author independently rated each trial on the PEDro Scale (<a href="./references#CD008816-bbs2-0070" title="MaherCG , SherringtonC , HerbertRD , MoseleyAM , ElkinsM . Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials. Physical Therapy2003;83(8):713‐21. ">Maher 2003</a>; <a href="./references#CD008816-bbs2-0058" title="deMortonNA . The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Australian Journal of Physiotherapy2009;55(2):129‐33. ">de Morton 2009</a>), using published and unpublished data from the trial investigators. The PEDro Scale was chosen because it has acceptably high reliability for individual ratings and for consensus ratings (<a href="./references#CD008816-bbs2-0070" title="MaherCG , SherringtonC , HerbertRD , MoseleyAM , ElkinsM . Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials. Physical Therapy2003;83(8):713‐21. ">Maher 2003</a>; <a href="./references#CD008816-bbs2-0075" title="ShiwaSR , CostaLCM , MoseleyAM , LopesAD , ReggeroCR , SatoTO , et al. Reproducibility of the Portuguese version of the PEDro scale. Cad Saúde Pública2011;27:2063‐2068. ">Shiwa 2011</a>). It has undergone extensive validation including convergent and construct validity and the appropriateness of the scoring system has been justified with Rasch analysis (<a href="./references#CD008816-bbs2-0058" title="deMortonNA . The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Australian Journal of Physiotherapy2009;55(2):129‐33. ">de Morton 2009</a>). The PEDro Scale is also widely used and understood by physiotherapists (<a href="./references#CD008816-bbs2-0063" title="ElkinsMR , MoseleyAM , SherringtonC , HerbertRD , MaherCG . Growth in the Physiotherapy EvidenceDatabase (PEDro) and use of the PEDroscale. British Journal of Sports Medicine2013;47(4):188‐189. ">Elkins 2013</a>). The Cochrane Risk of Bias tool has reliability that ranges from poor to slight (<a href="./references#CD008816-bbs2-0051" title="Armijo‐OlivoS , StilesCR , HagenNA , BiondoPD , CummingsGG . Asssessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract2012;18:12‐18. ">Armijo‐Olivo 2012</a>; <a href="./references#CD008816-bbs2-0064" title="HartlingL , OspinaM , LiangY , DrydenDNM , HootonN , Krebs SeidaJ , et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ2009;339:b4012. ">Hartling 2009</a>; <a href="./references#CD008816-bbs2-0065" title="HartlingL , HammMP , MilneA , VandermeerB , SantaguidaPL , AnsariM , et al. Testing the Risk of Bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. Journal of Clinical Epidemiology2013;66:973‐981. ">Hartling 2013</a>). </p> </section> <section id="CD008816-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data we planned to use the risk ratio (RR) with 95% confidence intervals (95% CIs) as a measure of treatment effect with an intention‐to‐treat analysis. An intention‐to‐treat analysis means that, where participants did not receive treatment as allocated, and were measures of outcomes were available, the analysis was performed as if participants received the treatment to which they were allocated. We considered a trial to have analysed by intention to treat if the report explicitly states that all participants received treatment or control conditions as allocated. Mortality and adverse events were the only dichotomous outcomes. </p> <p>For continuous data we planned to record the difference in mean change from baseline and standard deviation (SD) (or standard errors (SE)) for each group, or the final group means and SDs if change data are unavailable. We planned to calculate a pooled estimate of treatment effect using the mean difference (MD) with 95% CIs. </p> <p>However, given that both of the included trials were cross‐over in design, we used the generic inverse variance method. Where the MD and SE of the MD were available, we entered these directly into the meta‐analysis. Where only group means and SDs were available, we calculated the MD by subtraction of one group mean from the other. We imputed the SD of the differences from that obtained from the data in a similar trial, taking into account the paired nature of the data. We then calculated SEs using the formula: imputed SD / √n. </p> </section> <section id="CD008816-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>We incorporated data from cross‐over trials into meta‐analysis using the generic inverse variance method, involving expression of data in terms of the paired mean differences between treatments and their SE. We calculated these values either from paired individual patient data provided by authors, or by calculation of mean differences between interventions and their SE from means, SDs and P values reported in the manuscript (<a href="./references#CD008816-bbs2-0060" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). We intended to combine data from parallel‐designed trials with those from cross‐over trials in the meta‐analyses, but only cross‐over trials were obtained. If necessary, we intended to calculate the SEs in parallel trials from the MDs between treatments and their CIs, but only cross‐over trials were obtained. </p> </section> <section id="CD008816-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where data were absent or difficult to interpret in the presented form, we contacted the trial investigators in an attempt to obtain the data in a form that would facilitate data analysis. Had we not been able to obtain the data, our plan was to analyse only the available data (available‐case analysis). Additional data were obtained from the authors of the van Ginderdeuren trial (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). Additional data were sought from the authors of the O'Neill trial (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) and data were received for all requested outcomes. </p> </section> <section id="CD008816-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We visually inspected forest plots for overlap of the CIs and estimated statistical heterogeneity using the I² value (<a href="./references#CD008816-bbs2-0066" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). Given that thresholds for the interpretation of I² can be misleading (since the importance of inconsistency depends on several factors) we chose a rough guide to interpretation as follows: moderate heterogeneity was defined as an I² value of 30% to 60%, substantial heterogeneity was defined as an I² value of 50% to 90%, and considerable heterogeneity was defined as an I² value of 75% to 100%. The P value from the chi‐squared test was also used to interpret the importance of the observed value of I². Clinical heterogeneity was also assessed by considering differences in trial designs and participants characteristics. </p> </section> <section id="CD008816-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>If we had included sufficient trials in the review, we planned to assess publication bias using a funnel plot. If we suspected outcome reporting bias, we planned to contact trial investigators to clarify whether they measured and analysed certain outcomes and obtained the data. However, only two eligible trials were obtained; this was fewer than the recommended number of studies to construct a funnel plot so we were unable to assess whether outcome reporting bias was likely. </p> </section> <section id="CD008816-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We analysed the following between‐group comparisons where possible:</p> <p> <ol id="CD008816-list-0010"> <li> <p>hypertonic saline inhalation up to six hours before airway clearance techniques, compared to inhalation during airway clearance techniques; </p> </li> <li> <p>hypertonic saline inhalation up to six hours before airway clearance techniques, compared to up to six hours after airway clearance techniques; </p> </li> <li> <p>hypertonic saline inhalation during airway clearance techniques, compared to up to six hours after airway clearance techniques; </p> </li> <li> <p>morning compared to evening inhalation with any definition provided by the author. If not defined, we accepted midnight to midday as morning and midday to midnight as evening. </p> </li> </ol> </p> <p>We performed meta‐analyses using a fixed‐effect model. However, if we had observed substantial heterogeneity, we planned to use a random‐effects model. We planned to further explore heterogeneity in the planned subgroup analyses. </p> </section> <section id="CD008816-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned a subgroup analysis for different concentrations of hypertonic saline inhalation: low hypertonic concentrations (3% to 5%); medium (6% to 7%); and high (8% to 10%). We also planned to perform a subgroup analysis for intervention duration: less than two weeks; two to eight weeks; and greater than eight weeks. However, the included studies did not permit these analyses. </p> </section> <section id="CD008816-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses to assess the robustness of the review results by repeating the analyses with the following adjustments: </p> <p> <ul id="CD008816-list-0011"> <li> <p>exclusion of trials with unclear or inadequate sequence generation;</p> </li> <li> <p>exclusion of trials with unclear or inadequate allocation concealment;</p> </li> <li> <p>exclusion of trials that scored less than 5 out of 10 on the PEDro Scale (<a href="./references#CD008816-bbs2-0070" title="MaherCG , SherringtonC , HerbertRD , MoseleyAM , ElkinsM . Reliability of the PEDro Scale for Rating Quality of Randomized Controlled Trials. Physical Therapy2003;83(8):713‐21. ">Maher 2003</a>); </p> </li> <li> <p>modifying the definition of 'before' and 'after' airway clearance techniques to within 30 minutes of the techniques; </p> </li> <li> <p>with and without cross‐over trials.</p> </li> </ul> </p> <p>However, the included studies did not permit these analyses.</p> <section id="CD008816-sec-0045"> <h5 class="title">Summary of findings tables</h5> <p>In a post hoc change, we have presented three summary of findings tables, one for each comparison (<a href="./full#CD008816-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD008816-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD008816-tbl-0003">summary of findings Table 3</a>). We have included the following outcomes: FEV<sub>1</sub>, FVC, measures of QoL, symptom scores, measures of sputum clearance, lung clearance index and adverse events. </p> <p>We determined the certainty of the evidence using the GRADE approach; and downgraded evidence in the presence of: a high risk of bias in at least one study; indirectness of the evidence; unexplained heterogeneity or inconsistency; imprecision of results, or a high probability of publication bias. We downgraded evidence by one level if we considered the limitation to be serious and by two levels if very serious. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008816-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008816-sec-0046"></div> <section id="CD008816-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD008816-sec-0048"> <h4 class="title">Results of the search</h4> <p>The searches identified 104 trial reports which represented 50 trials.</p> </section> <section id="CD008816-sec-0049"> <h4 class="title">Included studies</h4> <p>Three trials were eligible for inclusion, which provided data for a total of 77 participants (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) (<a href="#CD008816-fig-0001">Figure 1</a>). One trial has not yet been published in full but has been presented as an oral presentation at a conference (although additional data has been provided by the trial authors) (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). No trial was identified regarding timing of hypertonic saline inhalation in relation to time of day. </p> <div class="figure" id="CD008816-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008816-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD008816-sec-0050"> <h5 class="title">Trial characteristics</h5> <p>The three included studies were randomised, cross‐over trials with concealed allocation, intention to treat analysis and blinded assessors (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). They investigated the impact of timing of hypertonic saline inhalation in relation to airway clearance techniques. The inhalation blocks were for one day. In one trial, three treatments of the allocated timing regimen were performed on each of the three trial days (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). In the second trial, a single treatment of 30 minutes was undertaken on each of the three trial days (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). One day was solely autogenic drainage and did not include hypertonic saline inhalation. This arm of the trial was not relevant to the study question of this review so the data were not included. The third trial also delivered a single treatment on each trial day, but only two timing regimens (inhalation before airway clearance techniques and inhalation during airway clearance techniques) were compared, so there were only two trial days (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> </section> <section id="CD008816-sec-0051"> <h5 class="title">Participants</h5> <p>Clarification of participant data was requested from the authors of the two of the three studies. One trial included 50 adults (mean (SD) age 31 (10) years, range 18 to 64 years) with a confirmed diagnosis of cystic fibrosis who were clinically stable with an FEV<sub>1</sub> within 10% of the best recorded value in the last six months (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). This trial excluded people who: were hypertonic saline naïve or previously intolerant; had received a lung transplant; were colonised with <i>Burkholderia cepacia</i> complex; were not clinically stable; had experienced haemoptysis greater than 60 mL within the last month; or were thrombocytopaenic or pregnant. The second trial recruited 13 hospitalised participants who were over 14 years (mean age 27 years, range 18 to 37 years) (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). All were productive daily and performed autogenic drainage for their airway clearance. The lung function of participants was not stated but some were noted to be on oxygen therapy. One participant withdrew after the first arm of the trial and therefore did not provide any cross‐over data that could be included in the analysis. The third study recruited 14 adults (mean (SD) age 33 (12) years), who were nearing the end of a course of intravenous antibiotics (days 10 to 14) for a pulmonary exacerbation of cystic fibrosis (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). Eligibility criteria included being productive of at least 10 g of sputum daily and demonstrated tolerance of hypertonic (7%) saline through either past or current use, The participants' mean (SD) FEV<sub>1</sub> was 51 (22) per cent predicted. </p> </section> <section id="CD008816-sec-0052"> <h5 class="title">Interventions</h5> <p>One trial administered 4 mL of 6% hypertonic saline via an LC Star (PARI, Germany) nebuliser three times per day with the allocated timing regimen for that day (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). Hypertonic saline was nebulised immediately before or after airway clearance, or during airway clearance with blocks of inhalation and pauses for airway clearance. Participants using positive expiratory pressure (PEP) devices were not permitted to administer hypertonic saline simultaneously as this alters the inhaled dose and the distribution of the deposition (<a href="./references#CD008816-bbs2-0069" title="LaubeBL , GellerDE , LinTC , DalbyRN , Diener‐WestM , ZeitlinPL . Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis. Respiratory Care2005;50:1438‐1444. ">Laube 2005</a>). The airway clearance technique was optimised for each participant on recruitment to the trial and was standardised for all three trial days. The second trial administered 4 mL of 6% hypertonic saline before or during 30 minutes of autogenic drainage (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). The third trial (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) administered 4mL of 7% hypertonic saline via a Portex updraft nebuliser (Smiths Medical, UK). Airway clearance involved 10 supervised cycles of oscillating PEP using the Acapella Duet device with forced expiration techniques, which in total required about 20 minutes. When hypertonic saline was allocated to be administered during airway clearance, this was achieved by attaching the updraft nebuliser to the Acapella Duet. On both days, 200 micrograms of salbutamol was administered 15 minutes before the commencement of the randomly allocation intervention for that day. The use of co‐interventions (such as bronchodilators and other inhaled medications) was not reported in the other two studies (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> </section> <section id="CD008816-sec-0053"> <h5 class="title">Outcomes measures</h5> <p>One trial measured the change in FEV<sub>1</sub> and FVC (in litres and percentage of the predicted value) recorded prior to and two hours following the middle treatment session of each trial day (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). Symptom scores at the end of each intervention arm were also recorded: perceived effectiveness; tolerability; and satisfaction rated on a 100‐mm visual analogue scale. Adverse events and adherence were also recorded. At the conclusion of the three‐day trial, participants reported their preferred timing regimen. </p> <p>The second trial reported the change in dyspnoea scores at the conclusion of each intervention arm, wet weight of sputum in grams produced during the treatment session, and adverse events and adherence (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> <p>The third trial reported FEV<sub>1</sub> and FEF<sub>25‐75</sub> as a percentage of the predicted value (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). Ease of use of the intervention and satisfaction with the intervention were also rated by the participants and the treating physiotherapists on a 100‐mm visual analogue scale. The wet weight of sputum produced and the number of coughs occurring during the allocated treatment session were also recorded, as was the wet weight of sputum during the subsequent 24 hours. Using a multiple breath washout test, the LCI and FRC were also recorded before, immediately after, and 90 minutes after each allocated treatment regimen. The duration of treatment was also noted. </p> </section> </section> <section id="CD008816-sec-0054"> <h4 class="title">Excluded studies</h4> <p>Of the remaining 46 studies identified through our search strategy, two were excluded because they did not involve the administration of hypertonic saline at all and one because the comparison of timing regimens was confounded by the use of different airway clearance techniques in the two arms of the study. A further 43 studies were excluded because the interventions they compared did not differ in the timing of hypertonic saline inhalation (<a href="./references#CD008816-bbs1-0002" title="">Excluded studies</a>). </p> </section> </section> <section id="CD008816-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>Please refer to <a href="#CD008816-fig-0001">Figure 1</a>; <a href="#CD008816-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD008816-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008816-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD008816-sec-0056"> <h4 class="title">Allocation</h4> <section id="CD008816-sec-0057"> <h5 class="title">Generation of sequence</h5> <p>All three trials reported adequate methods of random generation of the allocation sequence: computer‐generated list (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) and allocations drawn from a box that had been shaken (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). Thus, the overall risk of bias for all trials due to the method of generation of the random sequence was low. </p> </section> <section id="CD008816-sec-0058"> <h5 class="title">Concealment of allocation</h5> <p>Two trials reported using sealed opaque envelopes (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>) and one reported using an independent investigator to conceal the allocation list (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>), so the overall risk of bias for all trials due to the non‐concealment of allocation was low. </p> </section> </section> <section id="CD008816-sec-0059"> <h4 class="title">Blinding</h4> <p>In all trials, participants were not blinded to the timing regimen, leading to a high risk of bias. In all trials, outcome assessors were blinded to the timing regimen, leading to a low risk of bias. </p> </section> <section id="CD008816-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>All trials reported all available data. One trial stated no withdrawals occurred (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). The second trial stated that one participant withdrew after the first arm of the trial and therefore did not provide any cross‐over data that could be included in the analysis (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>) so analysis was conducted with all available data from 12 out of 13 participants (92%). The third trial ceased recruitment at 14 participants instead of the intended 31 because an interim analysis showed that the treatment was unlikely to be statistically or clinically significant (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). Additionally, one of the 14 participants withdrew and data were reported on the remaining 13 participants (93%). Therefore, the risk of bias due to attrition was low across all trials. </p> </section> <section id="CD008816-sec-0061"> <h4 class="title">Selective reporting</h4> <p>Two trials had a low risk of bias for this domain; one trial was prospectively registered and remained consistent with this protocol (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>); one trial was prospectively registered and reported all of the registered outcome measures, but some additional unregistered outcome measures (ease, satisfaction, cough and treatment duration) were also reported (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). The third trial was not registered and therefore had an unclear risk of bias (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> </section> <section id="CD008816-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were identified.</p> <p>All of the trials met the external validity criterion of the PEDro score by stating both the source of participants and the eligibility criteria. Both trials met eight of the ten internal validity criteria on the PEDro score, with neither trial blinding participants or therapists. </p> </section> </section> <section id="CD008816-sec-0063"> <h3 class="title" id="CD008816-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD008816-tbl-0001"><b>Summary of findings for the main comparison</b> Inhalation before compared with during airway clearance techniques for cystic fibrosis</a>; <a href="./full#CD008816-tbl-0002"><b>Summary of findings 2</b> Inhalation before compared with after airway clearance techniques for cystic fibrosis</a>; <a href="./full#CD008816-tbl-0003"><b>Summary of findings 3</b> Inhalation during compared with after airway clearance techniques for cystic fibrosis</a> </p> <section id="CD008816-sec-0064"> <h4 class="title">Inhalation before versus during airway clearance techniques</h4> <p>Three studies with a total of 77 participants contributed data to this comparison (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> <section id="CD008816-sec-0065"> <h5 class="title">Primary outcomes  </h5> <section id="CD008816-sec-0066"> <h6 class="title">1. Lung function</h6> <section id="CD008816-sec-0067"> <p><b>a. FEV<sub>1</sub> </b></p> <p>One trial (50 participants) provided data in litres for this outcome (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). The change in FEV<sub>1</sub> from immediately before a treatment to two hours later was higher on average when hypertonic saline was inhaled before airway clearance techniques, but this was not statistically significant (<a href="./references#CD008816-fig-0003" title="">Analysis 1.1</a>). Two trials (63 participants) reported estimates of the effect on FEV<sub>1</sub> using % predicted data, however, this difference was not statistically significant (low‐certainty evidence) (<a href="./references#CD008816-fig-0004" title="">Analysis 1.2</a>) (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> </section> <section id="CD008816-sec-0068"> <p><b>b. FVC</b></p> <p>One trial (50 participants) provided data for this outcome (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). The change in FVC from immediately before a treatment to two hours later was not statistically significantly different between trial arms when analysed using data in litres (<a href="./references#CD008816-fig-0005" title="">Analysis 1.3</a>). However, change in FVC from immediately before a treatment to two hours later was higher on average when hypertonic saline was inhaled before airway clearance techniques when analysed using % predicted data, with a MD of 2.09% pred (95% CI 0.08 to 4.11) (low‐certainty evidence) (<a href="./references#CD008816-fig-0006" title="">Analysis 1.4</a>). </p> </section> </section> <section id="CD008816-sec-0069"> <h6 class="title">2. Patient‐reported outcomes</h6> <section id="CD008816-sec-0070"> <p><b>a. QoL</b></p> <p>No trial reported this outcome.</p> </section> <section id="CD008816-sec-0071"> <p><b>b. Symptom scores</b></p> <p>Three studies with a total of 77 participants contributed data to this comparison (low‐certainty evidence) (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> <p>Cough in the 24 hours following treatment was reported for 13 participants in one trial (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). There was no significant difference between the groups in the number of coughs (<a href="./references#CD008816-fig-0007" title="">Analysis 1.5</a>). </p> <p>The remaining symptoms were all measured on a 100‐mm visual analogue scale.</p> <p>Dyspnoea was reported for 12 participants in one trial (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). There was no significant difference in the severity of dyspnoea between the groups (<a href="./references#CD008816-fig-0008" title="">Analysis 1.6</a>). </p> <p>Tolerability and perceived efficacy were reported for 50 participants in one trial (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>), there were no significant differences between the groups for either outcome (<a href="./references#CD008816-fig-0009" title="">Analysis 1.7</a>; <a href="./references#CD008816-fig-0010" title="">Analysis 1.8</a>). </p> <p>Ease of sputum clearance was reported for 13 participants in one trial (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). The same trial also reported data estimates of ease of sputum clearance from the treating physiotherapist. There were no significant between‐group differences for the patient ratings (<a href="./references#CD008816-fig-0011" title="">Analysis 1.9</a>), nor for the therapist ratings (<a href="./references#CD008816-fig-0012" title="">Analysis 1.10</a>). </p> <p>Satisfaction with the treatment regimen was rated by the patients in two trials (64 participants) (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). The pooled result of meta‐analysis indicated no significant difference between the groups (<a href="./references#CD008816-fig-0013" title="">Analysis 1.11</a>). The O'Neill trial also obtained data on satisfaction from the treating physiotherapist (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). Again there was no significant difference between the groups (<a href="./references#CD008816-fig-0014" title="">Analysis 1.12</a>). </p> </section> </section> </section> <section id="CD008816-sec-0072"> <h5 class="title">Secondary outcomes  </h5> <section id="CD008816-sec-0073"> <h6 class="title">1. Measures of sputum clearance</h6> <p>Two trials provided data from 25 participants for wet weight of sputum during the application of the intervention (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). The pooled result of meta‐analysis indicated no significant difference between the groups (low‐certainty evidence) (<a href="./references#CD008816-fig-0015" title="">Analysis 1.13</a>). One of the trials also collected data on wet weight of sputum for the 24 hours following treatment, again there was no significant difference between the groups (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) (<a href="./references#CD008816-fig-0016" title="">Analysis 1.14</a>). </p> </section> <section id="CD008816-sec-0074"> <h6 class="title">2. Measures of exercise capacity</h6> <p>None of the trials reported on this outcome.</p> </section> <section id="CD008816-sec-0075"> <h6 class="title">3. Mortality</h6> <p>No trial reported this outcome.</p> </section> <section id="CD008816-sec-0076"> <h6 class="title">4. Other pulmonary parameters</h6> <section id="CD008816-sec-0077"> <p><b>a. FEF<sub>25‐75</sub> </b></p> <p>One trial provided FEF<sub>25‐75</sub> data as % predicted for 13 participants (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>) There was no significant difference between the groups (<a href="./references#CD008816-fig-0017" title="">Analysis 1.15</a>). </p> </section> <section id="CD008816-sec-0078"> <p><b>e. FRC</b></p> <p>One trial (13 participants) provided data on FRC immediately after the treatment and 90 minutes later (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). There was no significant difference between the groups immediately after the treatment (<a href="./references#CD008816-fig-0018" title="">Analysis 1.16</a>) or at 90 minutes (<a href="./references#CD008816-fig-0019" title="">Analysis 1.17</a>). </p> </section> <section id="CD008816-sec-0079"> <p><b>f. LCI</b></p> <p>One trial provided data on LCI immediately after the treatment and 90 minutes later (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). There was no significant difference between the groups immediately after the treatment (<a href="./references#CD008816-fig-0020" title="">Analysis 1.18</a>) or at 90 minutes (low‐certainty evidence) (<a href="./references#CD008816-fig-0021" title="">Analysis 1.19</a>). </p> <p>No trial reported any of the other pulmonary parameters listed in the protocol.</p> </section> </section> <section id="CD008816-sec-0080"> <h6 class="title">5. Frequency of exacerbations of respiratory infection</h6> <p>No trial reported this outcome.</p> </section> <section id="CD008816-sec-0081"> <h6 class="title">6. Adherence to inhaled therapies, airway clearance techniques, and other therapies</h6> <p>There was 100% compliance with all the single doses of each treatment under supervision in all trials (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> </section> <section id="CD008816-sec-0082"> <h6 class="title">7. Adverse effects such as bronchospasm, cough and acute decline in pulmonary function</h6> <p>There were no adverse events in any trial (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> </section> </section> </section> <section id="CD008816-sec-0083"> <h4 class="title">Inhalation before versus after airway clearance techniques</h4> <p>One trial with 50 participants contributed data to this comparison (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). </p> <section id="CD008816-sec-0084"> <h5 class="title">Primary outcomes  </h5> <section id="CD008816-sec-0085"> <h6 class="title">1. Lung function (absolute change and change in per cent predicted if possible, otherwise final values) </h6> <section id="CD008816-sec-0086"> <p><b>a. FEV<sub>1</sub> </b></p> <p>The change in FEV<sub>1</sub> from immediately before a treatment to two hours later was not significantly influenced by whether hypertonic saline was inhaled before or after airway clearance techniques, whether analysed using data in litres (<a href="./references#CD008816-fig-0022" title="">Analysis 2.1</a>) or % predicted (low‐certainty evidence) (<a href="./references#CD008816-fig-0023" title="">Analysis 2.2</a>). </p> </section> <section id="CD008816-sec-0087"> <p><b>b. FVC</b></p> <p>The change in FVC from immediately before a treatment to two hours later was not significantly influenced by whether hypertonic saline was inhaled before or after airway clearance techniques, whether analysed using data in litres (<a href="./references#CD008816-fig-0024" title="">Analysis 2.3</a>) or % predicted (low‐certainty evidence) (<a href="./references#CD008816-fig-0025" title="">Analysis 2.4</a>). </p> </section> </section> <section id="CD008816-sec-0088"> <h6 class="title">2. Patient‐reported outcomes</h6> <section id="CD008816-sec-0089"> <p><b>a. QoL</b></p> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0090"> <p><b>b. Symptom scores</b></p> <p>Perceived efficacy (i.e. ease of clearance) was rated statistically significantly better when hypertonic saline was inhaled before versus after airway clearance techniques, MD 10.62 mm (95% CI 2.54 to 18.70) (low‐certainty evidence) (<a href="./references#CD008816-fig-0026" title="">Analysis 2.5</a>) </p> <p>Tolerability was not rated significantly differently when hypertonic saline was inhaled before versus after airway clearance techniques (low‐certainty evidence) (<a href="./references#CD008816-fig-0027" title="">Analysis 2.6</a>). </p> <p>Satisfaction was rated significantly better when hypertonic saline was inhaled before versus after airway clearance techniques, MD 20.38 mm (95% CI 12.10 to 28.66) (low‐certainty evidence) (<a href="./references#CD008816-fig-0028" title="">Analysis 2.7</a>). </p> </section> </section> </section> <section id="CD008816-sec-0091"> <h5 class="title">Secondary outcomes  </h5> <section id="CD008816-sec-0092"> <h6 class="title">1. Measures of sputum clearance</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0093"> <h6 class="title">2. Measures of exercise capacity</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0094"> <h6 class="title">3. Mortality</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0095"> <h6 class="title">4. Other pulmonary parameters</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0096"> <h6 class="title">5. Frequency of exacerbations of respiratory infection</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0097"> <h6 class="title">6. Adherence to inhaled therapies, airway clearance techniques, and other therapies</h6> <p>There was 100% compliance with all the single doses of each treatment.</p> </section> <section id="CD008816-sec-0098"> <h6 class="title">7. Adverse effects such as bronchospasm, cough and acute decline in pulmonary function</h6> <p>There were no adverse events in the trial.</p> </section> </section> </section> <section id="CD008816-sec-0099"> <h4 class="title">Inhalation during versus after airway clearance techniques</h4> <p>One trial with 50 participants contributed data to this comparison (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). </p> <section id="CD008816-sec-0100"> <h5 class="title">Primary outcomes  </h5> <section id="CD008816-sec-0101"> <h6 class="title">1. Lung function</h6> <section id="CD008816-sec-0102"> <p><b>a. FEV<sub>1</sub> </b></p> <p>The change in FEV<sub>1</sub> from immediately before a treatment to two hours later was not significantly influenced by whether hypertonic saline was inhaled before or after airway clearance techniques, whether analysed using data in litres (low‐certainty evidence) (<a href="./references#CD008816-fig-0029" title="">Analysis 3.1</a>) or % predicted (<a href="./references#CD008816-fig-0030" title="">Analysis 3.2</a>). </p> </section> <section id="CD008816-sec-0103"> <p><b>b. FVC</b></p> <p>The change in FVC from immediately before a treatment to two hours later was not significantly influenced by whether hypertonic saline was inhaled before or after airway clearance techniques, whether analysed using data in litres (low‐certainty evidence) (<a href="./references#CD008816-fig-0031" title="">Analysis 3.3</a>) or % predicted (<a href="./references#CD008816-fig-0032" title="">Analysis 3.4</a>). </p> </section> </section> <section id="CD008816-sec-0104"> <h6 class="title">2. Patient‐reported outcomes</h6> <section id="CD008816-sec-0105"> <p><b>a. QoL</b></p> <p>The trial dd not report this outcome.</p> </section> <section id="CD008816-sec-0106"> <p><b>b. Symptom scores</b></p> <p>Perceived efficacy (i.e. ease of clearance) was rated significantly better when hypertonic saline was inhaled during versus after airway clearance techniques, MD 15.60 mm (95% CI 17.55 to 23.65) (low‐certainty evidence) (<a href="./references#CD008816-fig-0033" title="">Analysis 3.5</a>). </p> <p>Tolerability was not rated significantly differently when hypertonic saline was inhaled during versus after airway clearance techniques (low‐certainty evidence) (<a href="./references#CD008816-fig-0034" title="">Analysis 3.6</a>). </p> <p>Satisfaction was rated significantly better when hypertonic saline was inhaled during versus after airway clearance techniques, MD 14.80 mm (95% CI 5.70 to 23.90) (low‐certainty evidence) (<a href="./references#CD008816-fig-0035" title="">Analysis 3.7</a>). </p> </section> </section> </section> <section id="CD008816-sec-0107"> <h5 class="title">Secondary outcomes  </h5> <section id="CD008816-sec-0108"> <h6 class="title">1. Measures of sputum clearance</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0109"> <h6 class="title">2. Measures of exercise capacity</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0110"> <h6 class="title">3. Mortality</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0111"> <h6 class="title">4. Other pulmonary parameters</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0112"> <h6 class="title">5. Frequency of exacerbations of respiratory infection</h6> <p>The trial did not report this outcome.</p> </section> <section id="CD008816-sec-0113"> <h6 class="title">6. Adherence to inhaled therapies, airway clearance techniques, and other therapies</h6> <p>There was 100% compliance with all the single doses of each treatment.</p> </section> <section id="CD008816-sec-0114"> <h6 class="title">7. Adverse effects such as bronchospasm, cough and acute decline in pulmonary function</h6> <p>There were no adverse events in the trial.</p> </section> </section> </section> <section id="CD008816-sec-0115"> <h4 class="title">Morning versus evening inhalation</h4> <p>No trial reported on this comparison.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008816-sec-0116" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008816-sec-0116"></div> <section id="CD008816-sec-0117"> <h3 class="title" id="CD008816-sec-0117">Summary of main results</h3> <p>The searches identified 51 studies, of which three studies were eligible for inclusion ‐ providing data for 77 participants. All studies used a cross‐over design. Intervention periods were short, so the overnight washout periods were probably appropriate. One trial provided three treatments in one day for each arm of the trial (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). The other two trials provided a single treatment for each arm of the trial on separate days (<a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> <p>There were no clinically important differences between the timing regimens of before, during or after airway clearance techniques in the mean amount of improvement in lung function, with the between‐group comparisons being non‐significant (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> <p>There were little or no differences in symptom scores when the timing regimens of before or during airway clearance techniques were compared. Outcomes included cough, dyspnoea, tolerability, ease of clearance and overall satisfaction (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). Ease of sputum clearance and overall satisfaction were also estimated by the treating physiotherapist in one trial, but there were little or no differences between the timing regimens (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). </p> <p>Perceived efficacy was between 10 and 20 mm lower on a 100‐mm scale when hypertonic saline was inhaled after physical airway clearance techniques, as opposed to before or during the techniques (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). Satisfaction with the entire treatment regimen may be lower when hypertonic saline was inhaled after physical airway clearance techniques, as opposed to before or during the techniques (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>). </p> <p>Additional outcomes for the before versus during timing comparison, which included wet weight of sputum (during and 24hours following), FEF<sub>25‐75</sub>, FRC (immediately and 90 minutes post), LCI (immediately and 90 minutes post), showed there may be little or no difference between these timing regimens (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>; <a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>; <a href="./references#CD008816-bbs2-0003" title="VanGinderdeurenF , VanlaethemS , EynsH , DeSchutterI , DewachterE , MalfrootA . Influence of inhaled hypertonic saline (NaCI 6%) before or during autogenic drainage on sputum weight, oxygen saturation, heart frequency and dysponoea in cystic fibrosis. Journal of Cystic Fibrosis2011;10 Suppl 1:S62. [CFGD Register: BD164; ] ">Van Ginderdeuren 2011</a>). </p> <p>One trial achieved delivery of hypertonic saline during airway clearance by using an Acapella duet device, which combines a nebuliser in series with an oscillating PEP mechanism (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>). Devices such as this may introduce additional considerations. For example, the Acapella duet device substantially reduces the duration of treatment (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>), but it also substantially reduces the dose received by the patient (<a href="./references#CD008816-bbs2-0053" title="BerlinskiA . In vitro evaluation of positive expiratory pressure devices attached to nebulizers. Respiratory Care2014;59(2):216‐22. ">Berlinski 2014</a>). These other issues were not included in the outcome measures of this systematic review, but clinicians should nevertheless consider these issues when deciding whether to use such a device to deliver hypertonic saline during airway clearance. </p> </section> <section id="CD008816-sec-0118"> <h3 class="title" id="CD008816-sec-0118">Overall completeness and applicability of evidence</h3> <p>No trials were found comparing morning versus evening inhalation of hypertonic saline. No trials were found in paediatric populations. Recommendations of the review are therefore limited to timing of inhalation in relation to airway clearance techniques in adults. </p> </section> <section id="CD008816-sec-0119"> <h3 class="title" id="CD008816-sec-0119">Quality of the evidence</h3> <p>The evidence for each outcome was rated as low according to the GRADE system, indicating that further research is very likely to have an important impact on our confidence in the estimates of effect and is likely to change the estimates. The GRADE result reflects two limitations of the included studies. The first issue is poor applicability, because studies included only adults so results are not applicable to children. The other issue is the lack of blinding. While it is often difficult for trials of physical interventions to achieve blinding, this was achieved in most of the trials in the Cochrane Review of timing of dornase alpha (<a href="./references#CD008816-bbs2-0059" title="DenticeR , ElkinsM . Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database of Systematic Reviews2018, Issue 11. [DOI: 10.1002/14651858.CD007923.pub5] ">Dentice 2018</a>) using a double‐dummy method. It is disappointing that none of the included trials in the present review used this method to achieve blinding. </p> </section> <section id="CD008816-sec-0120"> <h3 class="title" id="CD008816-sec-0120">Agreements and disagreements with other studies or reviews</h3> <p>This 2019 review update identified an additional trial (<a href="./references#CD008816-bbs2-0002" title="O'NeillK , MoranF , BradburyI , DowneyDG , RendallJ , TunneyMM , et al. Exploring the timing of hypertonic saline (HTS) and airways clearance techniques (ACT) in cystic fibrosis (CF): a crossover study. Thorax2016;71 Suppl 3:A134. [Abstract no: P95; CENTRAL: 1253123; CFGD Register: BD231a; CRS: 5500135000001677] O'NeillK , MoranF , TunneyMM , ElbornJS , BradburyI , DowneyDG , et al. Timing of hypertonic saline and airway clearance techniques in adults with cystic fibrosis during pulmonary exacerbation: pilot data from a randomised crossover study. BMJ Open Respiratory Research2017;4:e000168. [CFGD Register: BD231b] ">O'Neill 2016</a>), which shared outcome measures with the previous two eligible trials, permitting meta‐analysis for the before versus during timing comparison. One of the included studies did repeat the data collection on 14 participants within one year of doing the trial (<a href="./references#CD008816-bbs2-0001" title='DenticeR , ElkinsM , ByeP . Hypertonic saline before vs during vs after physiotherapy techniques for airway clearance in people with cystic fibrosis: A randomised trial. Physiotherapy2011;97:eS308‐eS309. [Abstract no.: RR‐PL‐3136; CENTRAL: 1089301; CRS: 5500050000000300; EMBASE: 71882596] DenticeR , ElkinsMR , ByePT . A randomised trial of the effect of timing of hypertonic saline inhalation in relation to airway clearance physiotherapy in adults with cystic fibrosis. Pediatric Pulmonology2010;Suppl 33:384. DenticeRL , ElkinsMR , ByePT . Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial. Journal of Physiotherapy2012;58(1):33‐40. [] DenticeRL , ElkinsMR , ByePT . Online Supplementary Material ‐ Table 3 : Individual outcome data to "Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial" [online]. Journal of Physiotherapy2012;58(1):33‐40 Online. [] '>Dentice 2012</a>), with very similar results to the original data collected on the 50 participants. </p> <p>The data identified by this review support the traditional approach of inhalation of hypertonic saline before airway clearance techniques, as has been used in previous studies demonstrating the efficacy of hypertonic saline for people with cystic fibrosis (<a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0024" title="ButtonBM , RiedlerJ , ReadeT , EngP , RobertsonCF . Inhaled hypertonic saline as an adjunct to chest physiotherapy in cystic fibrosis: The three‐year clinical experience. Pediatric Pulmonology1996;22(Suppl 13):306. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Efficacy of short‐term ultrasonically nebulised hypertonic saline in patients with cystic fibrosis. European Respiratory Journal1995;8(Suppl 19):510s. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Short‐term administration of ultrasonically nebulised hypertonic saline improves pulmonary function in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1995;25:440. EngPA , MortonJ , DouglassJA , RiedlerJ , WilsonJ , RobertsonCF . Short‐term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatric Pulmonology1996;21(2):77‐83. [MEDLINE: 97036562] ">Eng 1996</a>; <a href="./references#CD008816-bbs2-0039" title="RobinsonM , RegnisJA , BaileyDL , KingM , BautovichGJ , ByePT . Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;153(5):1503‐9. ">Robinson 1996</a>; <a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>). However, the data also suggest that inhalation during airway clearance may be equally effective. </p> <p>When advising about inhalation of hypertonic saline in relation to time of day, what issues might be considered in the absence of direct comparisons of different timing regimens of hypertonic saline? The trials demonstrating the efficacy of regular hypertonic saline have prescribed at least two doses per day (<a href="./references#CD008816-bbs2-0019" title="DonaldsonSH , BennettW , ZemanK , KnowlesMR , BoucherRC . Efficacy of amiloride and hypertonic saline in cystic fibrosis. Pediatric Pulmonology2003;Suppl 25:251. [CFGD Register: BD110a] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine2006;354(3):241‐50. [CFGD Register: BD110b] DonaldsonSH , BennettWD , ZemanKL , KnowlesMR , TarranR , BoucherRC . Online Supplement to 'Mucus clearance and lung function in cystic fibrosis with hypertonic saline' [online supplement]. New England Journal of Medicine2006; Vol. 354, issue 3:241‐50. [CFGD Register: BD110c] ">Donaldson 2006</a>; <a href="./references#CD008816-bbs2-0022" title="ByeP , ElkinsM , RobinsonM , MoriartyC , RoseB , HarbourC , et al. Long‐term inhalation of hypertonic saline in patients with cystic fibrosis‐ a randomised controlled trial. Pediatric Pulmonology2004;38(Suppl 27):329. [CFGD Register: BD114a] ElkinsM , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC , et al. Three methods of monitoring adherence in a long‐term trial in Cystic Fibrosis. Journal of Cystic Fibrosis2006;5(Suppl 1):S111. [Abstract no: 504; CFGD Register: BD114d] ElkinsMR , RobinsonM , MoriartyC , SercombeJ , RoseB , HarbourC . Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):268. [CFGD Register: BD114c] ElkinsMR , RobinsonM , RoseBR , HarbourC , MoriartyCP , MarksGB , et al. A controlled trial of long‐term inhaled hypertonic saline in patients with cystic fibrosis. New England Journal of Medicine2006;354(3):229‐40. [CFGD Register: BD114b] RatjenF . Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. Journal of Pediatrics2006;149(1):142. [CENTRAL: 1253122; CFGD Register: BD114e; CRS: 5500135000001675; PUBMED: 17243308] ">Elkins 2006c</a>; <a href="./references#CD008816-bbs2-0024" title="ButtonBM , RiedlerJ , ReadeT , EngP , RobertsonCF . Inhaled hypertonic saline as an adjunct to chest physiotherapy in cystic fibrosis: The three‐year clinical experience. Pediatric Pulmonology1996;22(Suppl 13):306. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Efficacy of short‐term ultrasonically nebulised hypertonic saline in patients with cystic fibrosis. European Respiratory Journal1995;8(Suppl 19):510s. EngP , MortonJ , DouglassJ , RiedlerJ , WilsonJ , RobertsonCF . Short‐term administration of ultrasonically nebulised hypertonic saline improves pulmonary function in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1995;25:440. EngPA , MortonJ , DouglassJA , RiedlerJ , WilsonJ , RobertsonCF . Short‐term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatric Pulmonology1996;21(2):77‐83. [MEDLINE: 97036562] ">Eng 1996</a>). The effect of single daily dosing on clinical outcomes is not known. Several studies suggest that as the dose of salt received is reduced, there is a reduction in hypertonic saline's effect on sputum rheology (<a href="./references#CD008816-bbs2-0068" title="KingM , DasguptaB , TomkiewiczRP , BrownNE . Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease. American Journal of Respiratory and Critical Care Medicine1997;156(1):173‐7. ">King 1997</a>; <a href="./references#CD008816-bbs2-0078" title="WillsPJ , HallRL , ChanW , ColePJ . Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus‐depleted bovine trachea. Journal of Clinical Investigation1997;99(1):9‐13. ">Wills 1997</a>), mucociliary clearance (<a href="./references#CD008816-bbs2-0040" title="RobinsonM , HemmingAL , BaileyDL , MellisCM , BautovichGJ , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine1996;154(Suppl):A70. RobinsonM , HemmingAL , RegnisJA , WongAG , BaileyDL , BautovichGJ , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax1997;52(10):900‐3. [MEDLINE: 98068190] RobinsonM , ParsonsS , HemmingA , BautovichG , MellisCM , ByePTP . Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Australian and New Zealand Journal of Medicine1997;27:258. ">Robinson 1997</a>), and perhaps some clinical outcomes (<a href="./references#CD008816-bbs2-0023" title="ElkinsMR , TingpejP , MoriartyCP , YozghatlianV , RoseBR , HarbourC , et al. Tolerability of hypertonic saline when delivered rapidly via the Eflow® rapid nebulizer in subjects with cystic fibrosis. Pediatric Pulmonlogy2006;41(Suppl 29):292. ">Elkins 2006d</a>). Therefore, individuals should be encouraged to take doses twice daily if tolerated; however, for those who only tolerate one dose per day and elect to pursue this regimen, a choice about diurnal timing must be made. In the absence of a randomised comparison of morning versus evening inhalation, individual factors such as convenience, compliance, and tolerability could be considered. For example, if an individual has a hectic morning schedule and spare time after their day's activities, evening inhalation may be more convenient. Conversely, if individuals note increased nocturnal coughing and sleep disturbance with evening inhalation, morning inhalation may be better tolerated. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008816-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008816-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008816-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 1 FEV1 (L)." data-id="CD008816-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 1 FEV<sub>1</sub> (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 2 FEV1 (% pred)." data-id="CD008816-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 2 FEV<sub>1</sub> (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 3 FVC (L)." data-id="CD008816-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 3 FVC (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 4 FVC (% pred)." data-id="CD008816-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 4 FVC (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 5 Coughs (n)." data-id="CD008816-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 5 Coughs (n). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 6 Dyspnoea (mm)." data-id="CD008816-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 6 Dyspnoea (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 7 Tolerability (mm)." data-id="CD008816-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 7 Tolerability (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 8 Perceived efficacy (mm)." data-id="CD008816-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 8 Perceived efficacy (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 9 Ease (mm)." data-id="CD008816-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 9 Ease (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 10 Ease rated by therapist (mm)." data-id="CD008816-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 10 Ease rated by therapist (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 11 Satisfaction (mm)." data-id="CD008816-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 11 Satisfaction (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 12 Satisfaction rated by therapist (mm)." data-id="CD008816-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 12 Satisfaction rated by therapist (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 13 Sputum wet weight immediately (g)." data-id="CD008816-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 13 Sputum wet weight immediately (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 14 Sputum wet weight next 24 hours (g)." data-id="CD008816-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 14 Sputum wet weight next 24 hours (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 15 FEF25‐75 (% pred)." data-id="CD008816-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 15 FEF<sub>25‐75</sub> (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 16 FRC immediately (L)." data-id="CD008816-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 16 FRC immediately (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 17 FRC at 90 min (L)." data-id="CD008816-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 17 FRC at 90 min (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 18 LCI immediately." data-id="CD008816-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 18 LCI immediately. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 19 LCI at 90 min." data-id="CD008816-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Inhalation before versus during airway clearance techniques, Outcome 19 LCI at 90 min. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 1 FEV1 (L)." data-id="CD008816-fig-0022" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 1 FEV<sub>1</sub> (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 2 FEV1 (% pred)." data-id="CD008816-fig-0023" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 2 FEV<sub>1</sub> (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 3 FVC (L)." data-id="CD008816-fig-0024" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 3 FVC (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 4 FVC (% pred)." data-id="CD008816-fig-0025" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 4 FVC (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 5 Perceived efficacy (mm)." data-id="CD008816-fig-0026" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 5 Perceived efficacy (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 6 Tolerability (mm)." data-id="CD008816-fig-0027" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 6 Tolerability (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 7 Satisfaction (mm)." data-id="CD008816-fig-0028" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Inhalation before versus after airway clearance techniques, Outcome 7 Satisfaction (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 1 FEV1 (L)." data-id="CD008816-fig-0029" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 1 FEV<sub>1</sub> (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 2 FEV1 (% pred)." data-id="CD008816-fig-0030" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 2 FEV<sub>1</sub> (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 3 FVC (L)." data-id="CD008816-fig-0031" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 3 FVC (L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 4 FVC (% pred)." data-id="CD008816-fig-0032" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 4 FVC (% pred). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 5 Perceived efficacy (mm)." data-id="CD008816-fig-0033" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 5 Perceived efficacy (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 6 Tolerability (mm)." data-id="CD008816-fig-0034" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 6 Tolerability (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008816-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/urn:x-wiley:14651858:media:CD008816:CD008816-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_t/tCD008816-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 7 Satisfaction (mm)." data-id="CD008816-fig-0035" src="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Inhalation during versus after airway clearance techniques, Outcome 7 Satisfaction (mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/media/CDSR/CD008816/image_n/nCD008816-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008816-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhalation before compared with during airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation before compared with during airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation before airway clearance techniques </p> <p><b>Comparison</b>: inhalation during airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation during airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation before airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to ˜2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.56% higher</b> (0.48% lower to 1.60% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>2.09% higher</b> (0.08% higher to 4.11% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All of the symptom scores suggest no statistically significant difference between the groups. </p> <p>This outcome includes a range of symptom scores from many different studies but number of participants contributing to each symptom score varies. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance: sputum wet weight immediately (g)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean wet weight of sputum during the application of the intervention was <b>0.26 g lower</b> (4.79 g lower to 4.27 g higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean wet weight of sputum for the 24 hours following treatment suggests no statistically significant difference between the groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> <p><b>Follow‐up: 90 minutes later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean LCI was <b>0.02 lower</b> (0.63 lower to 0.59 higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean LCI immediately after treatment suggests no statistically significant difference between the groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Inhalation before compared with during airway clearance techniques for cystic fibrosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008816-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhalation before compared with after airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation before compared with after airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation before airway clearance techniques </p> <p><b>Comparison</b>: inhalation after airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation after airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation before airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.75% higher</b> (0.45% lower to 1.95% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>1.66% higher</b> (1.42% lower to 4.74% higher) in the inhalation before airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FVC (L) showed no statistically significant difference between groups.</p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three symptom scores have been presented:</p> <p>Perceived efficacy shows a statistically significant difference in favour of inhalation before airway clearance techniques (MD 10.62; 95% CI 2.54 to 18.70) </p> <p>Tolerability showed no statistically significant difference between groups.</p> <p>Satisfaction shows a statistically significant difference in favour of inhalation before airway clearance techniques, MD 20.38 (95% CI 12.10 to 28.66) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Inhalation before compared with after airway clearance techniques for cystic fibrosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008816-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhalation during compared with after airway clearance techniques for cystic fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Inhalation during compared with after airway clearance techniques for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: inhalation during airway clearance techniques </p> <p><b>Comparison</b>: Inhalation after airway clearance techniques </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation after airway clearance techniques</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Inhalation during airway clearance techniques</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FEV<sub>1</sub> (% predicted) was <b>0.03% lower</b> (1.19% lower to 1.12% higher) in the inhalation during airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> (L) also showed no statistically significant difference between groups. </p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC % predicted</b> </p> <p><b>Follow‐up: before treatment to 2 hours later</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Not reported<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean FVC (% predicted) was <b>0.44% lower</b> (3.34% lower to 2.46% higher) in the inhalation during airway clearance techniques. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FVC (L) also showed no statistically significant difference between groups.</p> <p>Participants received both inhalation approaches as cross‐over design.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>QoL</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Symptom scores</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See comments.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊖⊖</p> <p><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three symptom scores have been presented:</p> <p>Perceived efficacy shows a statistically significant difference in favour of inhalation during airway clearance techniques, MD 15.60 (95% CI 7.55 to 23.65) </p> <p>Tolerability showed no statistically significant difference between groups.</p> <p>Satisfaction shows a statistically significant difference in favour of inhalation during airway clearance techniques, MD 14.80 (95% CI 5.70 to 23.90) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of sputum clearance</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>LCI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Outcome not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI</b> : confidence interval; <b>FEV<sub>1</sub> </b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>LCI</b> : lung clearance index; <b>MD</b> : Mean difference; <b>QoL</b>: quality of life </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. Only differences between inhalation before and during airway clearance techniques were presented, results within the inhalation during airway clearance techniques were not presented therefore an assumed risk cannot be calculated. </p> <p>2. Downgraded once due to high risk due to lack of blinding of participants and personnel.</p> <p>3. Downgraded once for lack of applicability as studies included only adults so results are not applicable to children. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Inhalation during compared with after airway clearance techniques for cystic fibrosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/full#CD008816-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008816-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhalation before versus during airway clearance techniques</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 FEV<sub>1</sub> (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [‐0.48, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 FVC (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Coughs (n) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Dyspnoea (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Tolerability (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Perceived efficacy (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Ease (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Ease rated by therapist (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Satisfaction (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.91 [‐1.58, 11.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Satisfaction rated by therapist (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Sputum wet weight immediately (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐4.79, 4.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Sputum wet weight next 24 hours (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 FEF<sub>25‐75</sub> (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 FRC immediately (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 FRC at 90 min (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 LCI immediately <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 LCI at 90 min <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inhalation before versus during airway clearance techniques</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008816-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inhalation before versus after airway clearance techniques</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 FEV<sub>1</sub> (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 FVC (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perceived efficacy (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Tolerability (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Satisfaction (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inhalation before versus after airway clearance techniques</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008816-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Inhalation during versus after airway clearance techniques</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 FEV<sub>1</sub> (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 FEV<sub>1</sub> (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 FVC (L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 FVC (% pred) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perceived efficacy (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Tolerability (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Satisfaction (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Inhalation during versus after airway clearance techniques</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008816.pub4/references#CD008816-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008816.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008816-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008816-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008816-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD008816-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD008816-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008816-note-0010">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD008816-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008816\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008816\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008816\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008816\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008816\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008816.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008816.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008816.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008816.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008816.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727527642"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008816.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727527646"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008816.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eae40cf5bf573',t:'MTc0MDcyNzUyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 